Publisher: Infection Control Today

Researchers at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced results from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV).

McCullers, a renowned infectious disease specialist and chair of the Department of Pediatrics at the University of Tennessee Health Science Center, analyzed the epidemiology and microbiology of co-infections during the 1918, 1957 and 1968 pandemics, as well as more recent 2009 novel H1N1 pandemic.